Novo Nordisk A S (NONOF) revenue by segment

NONOFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as NVO

Financials through fiscal 2025, year ended Dec 31, 2025Score 4/30

$38.24−0.60 (-1.53%)

Close on Oct 19, 2026Market cap $170.76BP/E 11.1Yield –

Novo Nordisk A S revenue by segment

Novo Nordisk A S does not break out revenue by segment, region or product in the tagged data of its filings for this period type.

See a number that looks wrong?